David D'Andrea, MD, Prof.

Clinical focus

Urologist specialising in urothelial oncology, minimally invasive surgical techniques, and the treatment of benign prostatic hyperplasia. His expertise includes managing non-muscle-invasive bladder cancer, BCG-unresponsive cases, and applying evidence-based surgical approaches for optimal functional and oncological outcomes.

About me

I am an Associate Professor of Urology at the Medical University of Vienna, where I lead a translational research program focused on urothelial cancer, particularly non-muscle-invasive and BCG-unresponsive cases. At the Medical University of Vienna (Dept. of Urology) I have held sustained managerial roles in academic healthcare. Over the years, I’ve been involved in a wide range of clinical trials and have contributed extensively to the development of prognostic models and surgical strategies that bridge research with real-world clinical application.

Since 2016, I have held continuous teaching and examining roles in urology and medical education. I am passionate about integrating scientific insight into daily urologic care to improve patient outcomes and support informed decision-making.

Experience and training

Experience

November 2019 – Today

Faculty Member, Department of Urology, Medical University of Vienna, Austria

November 2017 – November 2019

Consultant in Urology, Medical University of Vienna, Austria

February 2016 – October 2017

Resident in Urology, Medical University of Vienna, Austria

August 2011 – January 2016

Resident in Urology, Central Hospital of Bolzano, Italy

Education

September 2023

Associate Professor, Department of Urology, Medical University of Vienna, Austria

October 2021

Venia Docendi, Medical University of Vienna, Austria(Progressive development of prognostic models for response to intravesical bacillus Calmette-Guérin)

July 2020

ÖÄK Diploma in genetic counselling, Vienna, Austria

September 2017

Specialisation in Urology and Andrology, Vienna, Austria

June 2017

Fellow of the European Board of Urology (FEBU), European Board of Urology, Austria

March 2015

M.D. degree, Johannes Gutenberg Universität Mainz, Germany(Long-term experience in the use of botulinum toxin A for the treatment of neurogenic and non-neurogenic bladder dysfunctions)

April 2004 – May 2011

Medical Student, Medical School of Johannes Gutenberg Universität Mainz, Germany

Licensures and memberships

Licensure

70737-98, Austria

Memberships

• Associate Member of the EAU Guidelines Panel for Non-Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cancer
• Member of the Theodor-Billroth-Award and Erste Bank Research Award committee
• Member of the VFWF - Association for the Promotion of Science and Research at the University Hospital AKH Vienna
• Member of the European Association for Urology (EAU)
• Member of the Austrian Urologic-Oncology working group
• Member of the Austrian Association of Urology (ÖGU)
• Member of the Italian Association of Urology (SIU)

Publications

• [ReserachGate]https://www.researchgate.net/profile/David-Dandrea

Links

http://urologie-dandrea.at